drugset / Trial / NCT00070096
Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors
Phase 2
Completed
29 enrolled
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI) · collab
Open-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy, such as ixabepilone, work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well ixabepilone works in treating patients with metastatic germ cell tumors that are refractory to cisplatin.
Timeline
- Start
- 2003-08
- Primary completion
- —
- Completion
- 2007-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ixabepilone | Small molecule | — | Intravenous |